Cite
Prognostic Impact of Cytoskeleton Regulatory Protein Human Mena (hmena) Isoforms In Resected, Node-negative, Non-smallcell Lung Cancer: Validation of A Clinic-molecular Prognostic Model
MLA
Bria, Emilio, et al. Prognostic Impact of Cytoskeleton Regulatory Protein Human Mena (Hmena) Isoforms In Resected, Node-Negative, Non-Smallcell Lung Cancer: Validation of A Clinic-Molecular Prognostic Model. Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..10d1b7a26c0bc28e0e73db57426f15c1&authtype=sso&custid=ns315887.
APA
Bria, E., Mottolese, M., Francesca Di Modugno, Alessandrini, G., Ludovini, V., Antoniani, B., Iapicca, P., Ceribelli, A., Sidoni, A., Crino, L., Cognetti, F., Facciolo, F., Visca, P., Pilotto, S., Tortora, G., Sperduti, I., Milella, M., & Nistico, P. (2013). Prognostic Impact of Cytoskeleton Regulatory Protein Human Mena (hmena) Isoforms In Resected, Node-negative, Non-smallcell Lung Cancer: Validation of A Clinic-molecular Prognostic Model.
Chicago
Bria, Emilio, Marcella Mottolese, Francesca Di Modugno, Gabriele Alessandrini, Vienna Ludovini, Barbara Antoniani, Pierluigi Iapicca, et al. 2013. “Prognostic Impact of Cytoskeleton Regulatory Protein Human Mena (Hmena) Isoforms In Resected, Node-Negative, Non-Smallcell Lung Cancer: Validation of A Clinic-Molecular Prognostic Model,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..10d1b7a26c0bc28e0e73db57426f15c1&authtype=sso&custid=ns315887.